Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts
Andrea Eigentler(Innsbruck Medical University), Martin Puhr(Innsbruck Medical University)
Cited by 19
Related Papers
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling
|Endocrine Related Cancer|2010|41
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer
|American Journal Of Pathology|2024|3